Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research

Go back to Bruker Advances Functional Proteomics with Novel timsUltra AIP and timsOmni Workflows for Drug Discovery & Development and Disease Biology Research
Bruker Corporation (NASDAQ: BRKR) Delayed: 57.07 -4.93 (7.95%)
Previous Close $62.00    52 Week High $29.85 
Open $60.00    52 Week Low $19.59 
Day High $60.17    P/E 118.90 
Day Low $56.00    EPS $0.48 
Volume 1,921,334